Cytosorbents EPS - Earnings per Share 2010-2025 | CTSO
Cytosorbents eps - earnings per share from 2010 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Cytosorbents Annual EPS | |
|---|---|
| 2024 | $-0.38 |
| 2023 | $-0.65 |
| 2022 | $-0.75 |
| 2021 | $-0.57 |
| 2020 | $-0.20 |
| 2019 | $-0.60 |
| 2018 | $-0.56 |
| 2017 | $-0.32 |
| 2016 | $-0.46 |
| 2015 | $-0.38 |
| 2014 | $-1.29 |
| 2013 | $-0.75 |
| 2012 | $-0.75 |
| 2011 | $-1.25 |
| 2010 | $0.00 |
| 2009 | $0.00 |
| Cytosorbents Quarterly EPS | |
|---|---|
| 2025-03-31 | $-0.02 |
| 2024-12-31 | $-0.15 |
| 2024-09-30 | $-0.04 |
| 2024-06-30 | $-0.08 |
| 2024-03-31 | $-0.11 |
| 2023-12-31 | $-0.13 |
| 2023-09-30 | $-0.21 |
| 2023-06-30 | $-0.14 |
| 2023-03-31 | $-0.17 |
| 2022-12-31 | $-0.01 |
| 2022-09-30 | $-0.28 |
| 2022-06-30 | $-0.25 |
| 2022-03-31 | $-0.21 |
| 2021-12-31 | $-0.21 |
| 2021-09-30 | $-0.15 |
| 2021-06-30 | $-0.11 |
| 2021-03-31 | $-0.10 |
| 2020-12-31 | $0.00 |
| 2020-09-30 | $-0.02 |
| 2020-06-30 | $-0.08 |
| 2020-03-31 | $-0.10 |
| 2019-12-31 | $-0.13 |
| 2019-09-30 | $-0.21 |
| 2019-06-30 | $-0.11 |
| 2019-03-31 | $-0.15 |
| 2018-12-31 | $-0.17 |
| 2018-09-30 | $-0.10 |
| 2018-06-30 | $-0.19 |
| 2018-03-31 | $-0.10 |
| 2017-12-31 | $-0.13 |
| 2017-09-30 | $-0.07 |
| 2017-06-30 | $-0.06 |
| 2017-03-31 | $-0.06 |
| 2016-12-31 | $-0.18 |
| 2016-09-30 | $-0.09 |
| 2016-06-30 | $-0.12 |
| 2016-03-31 | $-0.07 |
| 2015-12-31 | $-0.13 |
| 2015-09-30 | $-0.11 |
| 2015-06-30 | $0.05 |
| 2015-03-31 | $-0.19 |
| 2014-12-31 | $-0.60 |
| 2014-09-30 | $-0.22 |
| 2014-06-30 | $-0.27 |
| 2014-03-31 | $-0.20 |
| 2013-12-31 | $0.00 |
| 2013-09-30 | $-0.25 |
| 2013-06-30 | $-0.25 |
| 2013-03-31 | $-0.25 |
| 2012-12-31 | $0.00 |
| 2012-09-30 | $-0.25 |
| 2012-06-30 | $-0.25 |
| 2012-03-31 | $-0.25 |
| 2011-12-31 | $-0.50 |
| 2011-09-30 | $-0.25 |
| 2011-06-30 | $-0.25 |
| 2011-03-31 | $-0.25 |
| 2010-12-31 | $0.00 |
| 2010-09-30 | $0.00 |
| 2010-06-30 | $0.00 |
| 2010-03-31 | $0.00 |
| 2009-12-31 | $0.00 |
| 2009-09-30 | $0.00 |
| 2009-06-30 | $0.00 |
| 2009-03-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.062B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $209.668B | 24.59 |
| Boston Scientific (BSX) | United States | $154.824B | 38.76 |
| Stryker (SYK) | United States | $148.439B | 31.04 |
| EssilorLuxottica (ESLOY) | France | $131.494B | 0.00 |
| Medtronic (MDT) | Ireland | $114.826B | 16.28 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.743B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.081B | 24.59 |
| ResMed (RMD) | United States | $37.598B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.909B | 16.57 |
| Agilent Technologies (A) | United States | $33.054B | 21.55 |
| Terumo (TRUMY) | Japan | $24.345B | 31.62 |
| Koninklijke Philips (PHG) | Netherlands | $23.697B | 16.63 |
| Insulet (PODD) | United States | $19.948B | 78.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.776B | 12.06 |
| Baxter (BAX) | United States | $14.312B | 10.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.087B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.794B | 23.64 |
| Lantheus Holdings (LNTH) | United States | $5.092B | 12.85 |
| Perrigo (PRGO) | Ireland | $3.733B | 9.46 |
| Prestige Consumer Healthcare (PBH) | United States | $3.713B | 16.58 |
| Haemonetics (HAE) | United States | $3.529B | 16.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.347B | 27.82 |
| ICU Medical (ICUI) | United States | $3.070B | 22.64 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.47 |
| QuidelOrtho (QDEL) | United States | $1.804B | 12.41 |
| AtriCure (ATRC) | United States | $1.473B | 0.00 |
| Acuren (TIC) | United States | $1.444B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.242B | 12.60 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| Phibro Animal Health (PAHC) | United States | $1.205B | 15.40 |
| Neogen (NEOG) | United States | $1.055B | 13.50 |
| BioLife Solutions (BLFS) | United States | $1.025B | 0.00 |
| InMode (INMD) | Israel | $0.891B | 8.98 |
| Kestra Medical Technologies (KMTS) | United States | $0.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.674B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.639B | 0.00 |
| Owens & Minor (OMI) | United States | $0.617B | 5.12 |
| Tilray Brands (TLRY) | Canada | $0.615B | 0.00 |
| Evolus (EOLS) | United States | $0.602B | 0.00 |
| CeriBell (CBLL) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.553B | 0.00 |
| Surmodics (SRDX) | United States | $0.438B | 0.00 |
| SNDL (SNDL) | Canada | $0.410B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.327B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Sanuwave Health (SNWV) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 75.83 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.96 |
| Biote (BTMD) | United States | $0.228B | 6.42 |
| Brainsway (BWAY) | Israel | $0.219B | 58.05 |
| Verano Holdings (VRNOF) | United States | $0.204B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.204B | 0.00 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.33 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.052B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.54 |
| Nephros (NEPH) | United States | $0.038B | 51.14 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |